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Succinylcholine is still the accepted standard for rapid sequence intubation.
1
Succinylcholine remains the drug of choice for rapid sequence intubation in the
emergency department or intensive care unit, unless there is a contraindication to
its usage.
2,3 However, it has some disadvantages, such as fasciculation, posto-
perative myalgia, and an increase of serum creatinin kinase.
4 Succinylcholine
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Purpose: The present visual and electromyographic study was designed to
evaluate muscle fasciculations caused by succinylcholine in adults pretreated with
either remifentanil 1.5 µg/kg or saline. Materials and Methods: The effect of
remifentanil on succinylcholine-induced muscle fasciculations was studied using a
double-blind method in 40 adults. After i.v. pretreatment with either remifentanil
1.5 µg/kg (remifentanil group, n = 20) or an equivalent volume of i.v. saline (saline
group, n = 20), patients were anaesthetized with a 2.0 mg/kg of i.v. propofol
followed by i.v. succinylcholine 1.0 mg/kg. Intensity and duration of muscle
fasciculation following i.v. succinylcholine administration were recorded. Electro-
myography (EMG) was used to quantify the extent of muscle fasciculation
following i.v. succinylcholine injection. Myalgia was evaluated 24 hours after
induction time. Serum potassium levels were measured five minutes after i.v.
succinylcholine administration and creatine kinase (CK) levels 24 hours after
induction time. Results: Compared to saline treated controls, remifentanil dec-
reased the intensity of muscle fasciculations caused by i.v. succinylcholine
[fasciculation severity scores (grade 0 to 3) were 2/1/12/5 and 3/13/4/0 (patients
numbers) in the saline group and the remifentanil group, respectively, p < 0.001].
The mean (SD) maximum amplitude of muscle action potential (MAP) by EMG
was smaller in the remifentanil group [283.0 (74.4) µV] than in the saline group
[1480.4 (161.3) µV] (p = 0.003). Postoperative serum CK levels were lower in the
remifentanil group (p < 0.001). Postoperative myalgia was not different between
the two groups. Conclusion: Remifentanil 1.5 µg/kg attenuated intensity of
muscle fasciculations by succinylcholine.
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induced fasciculation may be a causative factor of an in-
crease in intraocular, intracranial, or intragastric pressure.
5
Also, even though there are a few recent studies that show
otherwise,
5,6 it is a widespread belief that fasciculation is
the major cause of postoperative myalgia.
7,8
Therefore, the prevention of succinylcholine induced
muscle fasciculation may be an important strategy. Pre-
treatment with a small dose of a nondepolarizing muscle
relaxant is perhaps the most popular technique for preven-
tion of fasciculation. But with this technique, the risk of
potentially serious adverse effects is not negligible.
5
In children, fentanyl at 1 or 2 µg/kg inhibits muscle
fasciculations as effective as non-depolarizing relaxants,
9
and alfentanil 50 µg/kg, has been shown to inhibit muscle
fasciculations caused by succinylcholine in children and
young adults.
10 Remifentanil can be a suitable alternative to
alfentanil or fentanyl for attenuating muscle fasciculation
by i.v. succinylcholine as it has a shorter duration of action.
The present double blinded visual and electromyographic
study was designed to evaluate muscle fasciculation, myal-
gia, and changes in serum potassium and creatine kinase
(CK) concentrations caused by succinylcholine in adults
pretreated with either remifentanil 1.5 µg/kg or saline. 
After obtaining institutional Ethics Committee approval
and informed consent, we studied 40 (ASA I or II) patients
scheduled to undergo general anaesthesia for elective
otolaryngological surgery of about one hour duration with
tracheal intubation. This type of surgery was selected
because it presents a minimal risk of surgically induced
increases in serum CK. Patients with known cardiovas-
cular, pulmonary, or metabolic diseases, and those with an
impaired renal or hepatic function, morbid obesity, an age
< 18 or > 65, or a history of drug abuse were excluded. In
addition, patients with a neuromuscular disease and those
with an anticipated airway difficulty or at increased risk of
aspiration were also excluded. Using a random number
table, patients were assigned to one of two groups by one
anaesthesiologist, that is, to a saline group (normal saline
10 mL, n = 20) and remifentanil group (remifentanil 1.5
µg/kg diluted to 10 mL with normal saline, n = 20). Patients
in both groups were premedicated with glycopyrrolate
0.004 mg/kg i.v., 10 min before anaesthesia. 
Electromyography was used to quantify the extent of
muscle fasciculation after i.v. succinylcholine administra-
tion. This was performed by measuring muscle action
potentials (MAPs) at the biceps muscle in the arm without
an i.v. route. MAPs were measured using disposable
surface electrodes (11-mm diameter). For recording, the
standard tendon-mid muscle belly montage was used to
maximize MAP. Filters were set at 10 Hz and 10 kHz, and
the sensitivity and sweep speed used were 100 µV per and
1 s per division. All subjects were examined using a Sap-
phire electromyography machine (Medelec, Surrey, UK),
and recordings were performed by one investigator who
was unaware of injection details.
In the operating theatre, a bolus of saline 10 mL or remi-
fentanil 1.5 µg/kg diluted to 10 mL was administered over
30 s, 3 min after preoxygenation. When a bolus dose of i.v.
saline or remifentanil was given, i.v. propofol 2 mg/kg was
administered over 10 s. As soon as a patient lost consci-
ousness (based on loss of response to command and loss of
eyelash reflex), ventilation was attempted via a mask. Intra-
venous succinylcholine 1.0 mg/kg was given 60 s after com-
pleting the bolus administration of saline or remifentanil.
Laryngoscopy and tracheal intubation were performed
when visible muscle fasciculations stopped. The duration
and severity of visible muscle fasciculation were assessed
by one investigator, who was also unaware of the induc-
tion agent administered. Severity of fasciculation was
graded as described by Mingus, et al.
11: no fasciculations =
0; mild, fine fasciculations of the eyes, face, neck, or
fingers without limb movement = 1; moderate fascicula-
tions occurring on more than two sides or obvious limb
movement = 2; and vigorous or severe, sustained and
widespread fasciculations = 3. 
Rocuronium 0.3 mg/kg was administered for muscle
relaxation after tracheal intubation. Anaesthesia was main-
tained with 60% nitrous oxide in oxygen supplemented
with 2-3 vol% sevoflurane. After tracheal intubation,
patients were ventilated to maintain an end-tidal carbon
dioxide level between 32 and 37 mmHg. Blood samples
were drawn to determine serum potassium levels, without
stasis, before the induction of anaesthesia, and five minutes
after succinylcholine administration. Blood samples were
taken to determine CK levels before induction and 24
hours after induction time. 
Systolic blood pressures (SBPs) and heart rates (HR)
were recorded before induction of anaesthesia, pre-intuba-
tion, and at 1, 2, 3, and 5 min after tracheal intubation.
Hypotension (SBP < 80 mmHg for > 60 s) was treated with
i.v. ephedrine in 5 mg increments; bradycardia (heart rate
< 45 beat/min for > 60 s) was treated with i.v. atropine in
300 µg increments.
12
All the patients were interviewed by an investigator una-
ware of the induction agent used 24 hours after anesthetic
induction time postoperatively. Muscle pain not related to
surgical intervention was graded as described by Harvey,
et al.
13: absence of muscle pain = no myalgia; minor stiffness
limited to one area of the body = mild; muscle pain or
stiffness noticed spontaneously by the patient, possibly
MATERIALS AND METHODSRemifentanil and Succinylcholine
Yonsei Med J   http://www.eymj.org    Volume 51   Number 4   July 2010 587
requiring analgesic therapy = moderate; and generalized,
severe, or incapacitating discomfort = severe. No intramu-
scular injection was administered during the perioperative
period. Postoperative care was standardized for all pati-
ents. Pain related to surgical intervention was treated with
ketorolac 30 mg i.v. as required. 
Statistical analysis was performed using SPSS 15.0 for
Windows (SPSS Inc., Chicago, IL, USA). Sample size
calculations were performed based on fasciculation scores,
as described in a study that compared saline with alfen-
tanil, with respect to its inhibitory effect on muscle fasci-
culations caused by succinylcholine in adults [median
(range) fasciculation score from 0 to 3 were 2 (1-3) and 1
(0-2) in saline and alfentanil group, respectively].
10 With a
power of 80% and type 1 error of 5%, we calculated that
12 subjects were required per group. The Mann-Whitney
U test was used to compare the severity of fasciculations in
the two groups. The Student’s t-test or the Paired sample t-
test was used to analyze serum potassium and CK levels
between and within groups. Student’s t-test was used to
analyze parametric data and Mann-Whitney U test for non-
parametric data. Results are presented as mean (SD), and p
values of  < 0.05 were considered statistically significant. 
All patients were included in the statistical analysis, and
patient characteristics in the remifentanil and saline control
groups were similar (p > 0.05) (Table 1). The intensity of
visible muscle fasciculation in the remifentanil group was
less than in the saline group ( p > 0.01) (Table 2), whereas
the incidences and durations of visible muscle fascicula-
tion were similar in the two groups (p> 0.05). 
Mild myalgia occurred in 2 patients (10%) in the saline
group and in 1 patient (5%) in the remifentanil group. 
Visible muscle fasciculations were not observed in two
saline group patients but MAPs by electromyography
(EMG) were detected in all 20 patients. In the remifentanil
group, no visible muscle fasciculations were observed in
three patients, and one of them had no MAP by surface
EMG. Maximum MAP amplitudes were determined in all
patients, and mean (SD) maximum MAP amplitude was
smaller in the remifentanil group [283 (74.4) µV vs. 1480.4
(161.3) µV, p = 0.003]. The mean (SD) duration of MAPs
in the remifentanil group was similar to that of the saline
group [21.3 (3.9) s vs 26.8 (3.3) s, p > 0.05]. Typical EMG
recordings are shown in Fig. 1. 
Mean post-intubation serum potassium concentrations
increased significantly from preoperative values in both
groups (p < 0.001) (Table 3), but mean potassium concen-
trations at pre-induction and 5 min after tracheal intubation
were not different in the two groups (p > 0.05). Post-opera-
tive mean CK levels increased significantly from their pre-
operative values in both groups (p ≤ 0.001) (Table 3), and
the mean post-operative CK level in the remifentanil group
RESULTS
Table 1.Patient Characteristics
Group Sex (M / F) Age (yrs) Weight (kg)
Saline (n = 20) 10 / 10 42.0 (22 - 65) 62.9 (50 - 86)
Remifentanil (n = 20) 10 / 10 43.4 (30 - 65) 63.0 (42 - 87)
Data are presented as numbers of patients and means (range). Saline group (control) members were pretreated with saline. Remifentanil 
group members were pretreated with remifentanil 1.5 µg/kg. p> 0.05.
Table 2.Visible Muscle Fasciculations after I.V. Succinylcholine 
Group
Number (%)  Fasciculation scores Duration of 
with fasciculation 0 1 2 3 fasciculation (s)
Saline (n = 20) 18 (90) 2 1 12 5 59.6 (21.8)
Remifentanil (n = 20)* 17 (85) 3 13 4 0 41.6 (7.7)
Data are numbers of patients (%) and numbers of patients and mean (SD). Saline = the control group pretreated with saline. Remifentanil = 
the group pretreated with remifentanil 1.5 µg/kg. Fasciculation scores: 0 = none; 1 = mild; 2 = moderate; 3 = vigorous. 
*p< 0.05 vs. fasciculation score of the saline group.
Table 3.Serum Potassium and Creatine Kinase Concentrations
Group
Potassium (mEq/L) Creatine kinase (IU/L)
Pre-induction Post-intubation Pre-induction 24 hr after induction time
Saline (n = 20) 3.6 (0.1) 3.9 (0.1)* 67.0 (18.0) 225.7 (24.1)*
Remifentanil (n = 20) 3.6 (0.2) 3.9 (0.3)* 63.9 (14.4) 139.7 (53.3)*
�
Data are presented as means (SD). Saline group (control) members were pretreated with saline. Remifentanil group members were 
pretreated with remifentanil 1.5 µg/kg. 
*p< 0.05 vs. pre-induction. 
�p< 0.05 vs. the saline group.was lower than in the saline group (p< 0.001). 
Two patients had hypotension (72-80 mmHg) at prein-
tubation and at 2, 3, and 5 min after tracheal intubation in
the remifentanil group. One of these two patients was
treated with ephedrine 5 mg due to hypotension (SBP 72,
76 mmHg) for > 60 s. None of the patients had bradycardia
(a heart rate < 45 beat/min for > 60 s) requiring treatment. 
Two patients in each group were administered ketorolac
(30 mg i.v.) within the first 24 hours postoperatively due to
operation-related pain.
The present study shows that remifentanil 1.5 µg/kg decre-
ases the intensity of visible muscle fasciculations and EMG
activity caused by succinylcholine in adults. Maximum
MAP amplitude provides an objective means of quanti-
fying the severity of visible muscle fasciculations, but it
was not utilized in previous similar studies.
9,10 
However, the incidence and duration of muscle fascicu-
lation were not significantly different between the two
groups, which is similar with the study that compared
alfentanil with saline.
10 The incidence and severity of myal-
gia also showed no significant difference. Only mild
myalgia occurred in both group, 10% in the saline group,
and 5% in the remifentanil group. Thus, the results of the
present study correspond with studies reporting that there
is no direct correlation between intensity of fasciculation
and frequency of myalgia, and it is more likely that the
etiology of myalgia is multifactorial.
6,14-16 The results also
correspond with the study reporting that the use of opioid
during induction is not related with postoperative myalgia.
5
Although the incidence of myalgia was low in both
groups, the CK levels significantly increased in both
groups when checked 24s hour after anesthetic induction
time. But the CK level 24 hours after anesthetic induction
time was significantly lower in the remfentanil group when
compared to the saline group. It seems likely that this is
related to the fact that the intensity of fasciculation was
lower in the remifentanil group. These results also corres-
pond to studies that reported that the incidence of myalgia
does not correlate with CK, which is the biochemical mark-
er of muscle damage.
17,18 However, increases in serum po-
tassium were not restricted by remifentanil. This is similar
to that found in another study in which the muscle fasci-
culation was reduced but no difference in serum potassium
was observed when pretreatment with d-tubocurarine was
compared with no pretreatment.
19
The mechanism of the inhibitory action of remifentanil
on succinylcholine-induced muscle fasciculation remains
unexplained. Morphine and nalorphine inhibit neuromus-
cular transmission in mammalian and amphibian neuro-
muscular preparations by impairing the release of acetyl-
choline.
20-22 Also resting tension of the indirectly stimulated
rat hemidiaphragm increases slowly in the presence of
high concentrations of morphine.
21 The animal studies indi-
cate that morphine can significantly impair neurohumoral
transmission at peripheral muscarinic receptors.
23
Pretreatment with a small dose of non-depolarizing
muscle relaxant, although widely used to reduce succinyl-
choline-induced fasciculation, posses many risks including
heavy eyelids, blurred vision, diplopia, and difficulty in
breathing or swallowing.
11,24 It also causes the usage of a
higher dose of succinylcholine in order to obtain optimal
intubating condition which leads to a longer recovery and
apnea period.
25
Due to an extremely short elimination half-life, the plasma
level of remifentanil decreases rapidly after discontinua-
tion.
26 According to our present study, the usage of remi-
fentanil reduces the intensity of fasciculation caused by
succinylcholine. This effect can be very useful when using
succinylcholine in emergency situations by reducing the
risk of regurgitation of gastric contents, since it is known
that in adults the intensity of fasciculation is directly relat-
ed with the increase of intragastric pressure in adults.
27
Although remifentanil has the advantage of blocking the
sympathetic activation during tracheal intubation,
12,28 it can
also cause adverse effects such as hypotension and brady-
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DISCUSSION
Fig. 1. Typical EMG recordings from the biceps of two patients pretreated with
saline or remifentanil. EMG recordings during succinylcholine-induced muscle
fasciculation in a patient pretreated with saline (A) or remifentanil (B). Arrows
indicate times of i.v. succinylcholine (1.0 mg/kg) administration. Dotted arrow =
maximum amplitude. EMG, electromyography.
100 uV
1 s
A
BRemifentanil and Succinylcholine
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cardia. Although hypotension occurred in 2 patients in the
remifentanil group, bradycardia did not. It could be that
pretreatment with glycopyrrolate prevented the adverse
effect of remifentanil. Muscle rigidity, another well-known
side effect of remifentanil, was also not observed. It is
likely that prompt administration of propofol and succiny-
lcholine blocked the incidence. 
The dose of remifentanil selected (1.5 µg/kg) in the pre-
sent study was based on the findings of previous studies in
which remifentanil administered as a 1 µg/kg bolus follow-
ed by a 0.5 µg/kg infusion,
12 or as a bolus of 1-2 µg/kg,
effectively attenuated or blocked haemodynamic responses
to laryngoscopy and intubation.
28 However, the pretreatment
of elderly or sick patients with remifentanil (1.5 µg/kg)
should be carefully undertaken or be avoided because of
possible hypotension and bradycardia.
23 Further studies are
required to optimize dosage regimens. 
In conclusion, remifentanil 1.5 µg/kg attenuated inten-
sity of muscle fasciculations by succinylcholine. 
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